Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

KLK3 / Kallikrein 3 Antikörper

Sino Biological Inc. liefert KLK3 / Kallikrein 3 Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über KLK3 / Kallikrein 3 Antikörper lesen Sie bitte: http://www.sinobiological.com/KLK3-Kallikrein-3-Antibody-g-10104.html

Produkt-Information von KLK3 / Kallikrein 3 Antikörper

Immunogen

Recombinant Human KLK3 / Kallikrein 3 protein (Catalog#10771-H08H)

Antibody Type Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform )

Clone ID

007

Ig Type

Rabbit IgG

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

This antibody was obtained from a rabbit immunized with purified, recombinant Human KLK3 / Kallikrein 3 (rh KLK3 / Kallikrein 3; Catalog#10771-H08H; P07288; Met 1-Pro 261).

Usage Guide von KLK3 / Kallikrein 3 Antikörper

Specificity

Human KLK3 / Kallikrein 3

Direct ELISA This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human KLK3. The detection limit for Human KLK3 is approximately 0.0195 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von KLK3 / Kallikrein 3 Antikörper

Related Areas:

Enzyme>>Protease & Regulator>>Serine Protease & Regulator>>Kallikrein>>KLK3/Kallikrein 3

Cancer>>Angiogenesis>>Kallikrein>>KLK3/Kallikrein 3

Cancer>>Cancer Biomarkers>>KLK3/Kallikrein 3

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
KLK3/Kallikrein 3 Human KLK3/Kallikrein 3 Protein, Recombinant 10771-H08H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human KLK3/Kallikrein 3 WB, ELISA KLK3 / Kallikrein 3 Antibody 10771-RP01
Human KLK3/Kallikrein 3 WB, ELISA KLK3 / Kallikrein 3 Antibody (Antigen Affinity Purified) 10771-RP02
Human KLK3/Kallikrein 3 ELISA KLK3 / Kallikrein 3 Antibody 10771-R007

Hintergrund von KLK3 / Kallikrein 3 Antikörper

Prostate-specific antigen, also known as Gamma-seminoprotein, Kallikrein-3, kallikrein-related peptidase 3, Semenogelase, KLK3 and PSA, is a secreted protein which belongs to thepeptidase S1 family and Kallikrein subfamily. KLK3/Kallikrein 3 contains one peptidase S1 domain. KLK3/Kallikrein 3 is a glycoprotein produced almost exclusively by the prostate gland. KLK3/Kallikrein 3 is produced for the ejaculate where it liquifies the semen in the seminal coagulum and allows sperm to swim freely.It is also believed to be instrumental in dissolving the cervical mucous, allowing the entry of sperm. Human KLK3/Kallikrein 3 and human KLK2 are closely related products of the human kallikrein genes KLK3 and KLK2, respectively. Both KLK3/Kallikrein 3 and human kallikrein 2 are produced and secreted in the prostate and have important applications in the diagnosis of prostate cancer. Understanding the mechanism by which genetic variation in KLK3/Kallikrein 3 affects prostate cancer risk has important implications for study of the biological role of KLK3/Kallikrein 3 in prostate tumorigenesis.

References

  1. Koistinen,H. et al., 2008, Biol Chem. 389 (6): 633-42.
  2. David,A. et al.,2002, J Biol Chem. 277 (20): 18084-90.
  3. Andriole GL, et al., 2009, New Eng. J. Med. 360 (13): 1310.
  4. Schroder FH, et al., 2009, New Eng. J. Med. 360 (13): 1320.

Primary Antibody Products

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post